Logo

codevelopment agreement

Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs

The companies are working together to bring to market in vitro diagnostic versions of Thermo Fisher's Oncomine Comprehensive Assay Plus and Oncocyte's DetermaIO test.

Illumina, SomaLogic Ink Codevelopment Agreement for Proteomics Assays With Sequencing Readout

Illumina will endeavor to integrate SomaLogic's aptamer-based protein counting technology with its NGS and bioinformatics platforms by 2024.

Sophia Genetics Touts Informatics Deals With Weill Cornell, Agilent, Dasa
Premium

Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships.

Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs

The next-generation sequencing based companion diagnostics will be paired with targeted therapies that are being developed for several diseases.

GenomSys, Philips to Build Genome Analysis Technology Based on MPEG-G Standard

The multiyear collaboration agreement brings together two of the corporate champions of the MPEG-G genomic data representation and compression standard.

Jul 6, 2021

Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare

Apr 22, 2021

Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic

Apr 15, 2021

Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing
Premium

Feb 24, 2021

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Feb 9, 2021

UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing
Premium

Nov 18, 2020

Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures

Aug 6, 2020

Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech

Jul 17, 2020

Saga Diagnostics, SensID to Codevelop Control Reagents for Cancer Mutation Detection

Jul 1, 2020

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test
Premium

May 5, 2020

CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test

Mar 17, 2020

Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease

Jan 15, 2020

PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay

Jan 13, 2020

Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Dec 3, 2019

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Nov 7, 2019

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

Nov 6, 2019

Mission Bio, BioLegend Partner on Single-Cell DNA-Protein Detection

Oct 4, 2019

Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD

Sep 24, 2019

Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays

Sep 16, 2019

Interpace Diagnostics, Genecast Biotechnology Ink Worldwide Research Services Agreement

Sep 11, 2019

Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board
Premium

Breaking News
The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.